Acute myeloid leukemia, or AML, is a type of blood cancer that starts in the bone marrow and rapidly moves to the bloodstream. It can spread to other parts of the body, including the lymph nodes, liver, and nervous system. AML, which accounts for about 1% of all cancers, could result in 11,090 deaths this year, according to the American Cancer Society.
The company we are profiling today is a late-stage clinical biopharmaceutical company developing a WT1-targeting cancer immunotherapeutic for acute myeloid leukemia - SELLAS Life Sciences Group Inc. (SLS).
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.